Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
12.08.24
/
50%
€21.28
Target price
12.08.25
€50.31
Performance (%)
-28.88%
End price
13.08.25
€15.14
Summary
This prediction ended on 13.08.25 with a price of €15.14. The price of Arrowhead Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.88%. B__Riley has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -0.995% | -0.995% | 192.992% |
| iShares Core DAX® | 1.232% | 1.501% | 11.288% |
| iShares Nasdaq 100 | 0.695% | -1.949% | 5.586% |
| iShares Nikkei 225® | 2.085% | 11.061% | 31.150% |
| iShares S&P 500 | 0.419% | 0.215% | 4.116% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten
Current prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.50
22.01.26
22.01.26
€86.40
22.01.27
22.01.27
-9.71%
26.02.26
26.02.26
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.85
14.02.25
14.02.25
€36.16
14.02.26
14.02.26
185.20%
15.02.26
15.02.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24